S T Wilkinson1, M R Grunwald2, J J Paik3, L W Ostrow4, A C Gelber5. 1. From the Department of Psychiatry, Yale School of Medicine, 300 George St, STE 901, New Haven CT 06511. 2. Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, 1021 Morehead Medical Drive, Suite 5300, Charlotte, NC 28204. 3. Department of Medicine, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F Lord Bldg, Center Tower, STe 4100, Baltimore, MD 21224 and. 4. Department of Neurology, Johns Hopkins University School of Medicine, The John G. Rangos Sr. Building, 855 N. Wolfe St., Neurology 248, Baltimore, MD 21205, USA. 5. Department of Medicine, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F Lord Bldg, Center Tower, STe 4100, Baltimore, MD 21224 and agelber@jhmi.edu.
Authors: Anthony A Hilliard; Steven E Weinberger; Lawrence M Tierney; David E Midthun; Sanjay Saint Journal: N Engl J Med Date: 2004-02-05 Impact factor: 91.245
Authors: Meena Kalluri; Steven A Sahn; Chester V Oddis; Suzanne L Gharib; Lisa Christopher-Stine; Sonye K Danoff; Livia Casciola-Rosen; Grace Hong; Paul F Dellaripa; Kristin B Highland Journal: Chest Date: 2009-02-18 Impact factor: 9.410